Status:

UNKNOWN

The Study of Mechanism of Chronic Insomnia Disorder Using Acupuncture Based on Changes of Brain GABA and fMRI

Lead Sponsor:

Dongfang Hospital Beijing University of Chinese Medicine

Collaborating Sponsors:

Xuanwu Hospital, Beijing

First Affiliated Hospital Xi'an Jiaotong University

Conditions:

Insomnia Disorder

Eligibility:

All Genders

25-75 years

Phase:

NA

Brief Summary

Insomnia disorder is one of the major neuropsychiatric diseases which received more attention in recent years. Disturbances in the amino acid neurotransmitter, gama-amino butyric acid (GABA) and hyper...

Detailed Description

Three groups of subjects (CID accepted true acupuncture, CID accepted sham acupuncture and healthy) will participate in the study. All subjects will undergo a laboratory blood test, physical and neuro...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of chronic insomnia disorder (CID) met the criteria of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
  • Subject has history of chronic insomnia (difficulty with sleep induction, awakenings during the night, early morning awakening) of at least 3 months
  • Must be able to cooperate with cognitive testing and MRI scan

Exclusion

  • Known pre-existing sleep disorder other than chronic insomnia disorder
  • Circadian rhythm sleep disorder determined by sleep-wake cycles of sleep (such as work time at day and night alternation)
  • Severe general medical disorders of cardiovascular, endocrine, renal, or hepatic systems
  • Clinical diagnosis of AD or Parkinson's neurodegenerative diseases
  • Moderate or severe psychological illness
  • Clinical history of stroke or other severe cerebrovascular disease
  • Clinical history of malignancies disease
  • Active treatment with antipsychotic medications, benzodiazepines or other hypnotic agents (i.e. Trazodone, Mirtazapine, Zolpidem, Zaleplon)
  • Alcohol or drug abuse

Key Trial Info

Start Date :

December 26 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03237338

Start Date

December 26 2017

End Date

December 31 2021

Last Update

July 9 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dongfang Hospital Affiliated to Beijing University of Chinese Medicine

Beijing, China